MSK Trademark
Trademark Overview
On Monday, July 14, 2025, a trademark application was filed for MSK with the United States Patent and Trademark Office. The USPTO has given the MSK trademark a serial number of 99281840. The federal status of this trademark filing is APPROVED FOR PUBLICATION as of Wednesday, June 10, 2026. This trademark is owned by Memorial Sloan-Kettering Cancer Center. The MSK trademark is filed in the Insurance & Financial Services, Education & Entertainment Services, Computer & Software Services & Scientific Services, and Medical & Beauty Services & Agricultural Services categories with the following description:
Educational services, namely, training clinicians and healthcare providers in analysis of clinical data utilizing diagnostic, clinic-genomic, and harmonized oncologic dataset and database models pertaining to cancer outcome predictions and treatment recommendations; Educational services, namely, conducting community lectures on cancer and related health issues, and distribution of related informational materials therewith; Educational services, namely, conducting classes, seminars, training programs, correspondence courses, and scientific conferences via television, radio, and global computer networks, all in the fields of medicine and biomedical sciences.
Charitable fundraising services by means of raising money for cancer research, cancer treatment, cancer awareness and the construction of facilities for use in cancer research, cancer treatment and cancer awareness.
Medical services; Healthcare services for treating cancer; Hospital services, namely, patient treatment and care; pharmaceutical prescription formulation being compounding, and dispensing services; providing medical services in the nature of patient health consultations for patients and providing medical information via telemedicine, videoconferencing, and teleconferencing software
Research in the biomedical sciences fields, namely, molecular biology, cell biology, genetics, and immunology; Healthcare services for treating cancer; Hospital services, namely, patient treatment and care; Pharmaceutical prescription formulation being compounding, and dispensing services; Medical research and development services pertaining to the development of cancer vaccines that target neoantigens; Scientific research services in the biomedical sciences fields of molecular biology, cell biology, genetics, and immunology; Compiling medical data for research purposes in the field of gene mutations in rare and common cancers for evaluation and assessing tumor biology, prognosis, and treatment and patient drug response; Providing non-downloadable on-line software, software applications, software tools, and databases using natural language processing and machine learning algorithms, for extracting, characterizing, defining, annotating, curating, structuring, and communicating clinical ...
General Information
| Serial Number | 99281840 |
| Word Mark | MSK |
| Filing Date | Monday, July 14, 2025 |
| Status | 680 - APPROVED FOR PUBLICATION |
| Status Date | Wednesday, June 10, 2026 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | NOT AVAILABLE |
Trademark Statements
| Goods and Services | Educational services, namely, training clinicians and healthcare providers in analysis of clinical data utilizing diagnostic, clinic-genomic, and harmonized oncologic dataset and database models pertaining to cancer outcome predictions and treatment recommendations; Educational services, namely, conducting community lectures on cancer and related health issues, and distribution of related informational materials therewith; Educational services, namely, conducting classes, seminars, training programs, correspondence courses, and scientific conferences via television, radio, and global computer networks, all in the fields of medicine and biomedical sciences. |
| Goods and Services | Charitable fundraising services by means of raising money for cancer research, cancer treatment, cancer awareness and the construction of facilities for use in cancer research, cancer treatment and cancer awareness. |
| Goods and Services | Medical services; Healthcare services for treating cancer; Hospital services, namely, patient treatment and care; pharmaceutical prescription formulation being compounding, and dispensing services; providing medical services in the nature of patient health consultations for patients and providing medical information via telemedicine, videoconferencing, and teleconferencing software |
| Goods and Services | Research in the biomedical sciences fields, namely, molecular biology, cell biology, genetics, and immunology; Healthcare services for treating cancer; Hospital services, namely, patient treatment and care; Pharmaceutical prescription formulation being compounding, and dispensing services; Medical research and development services pertaining to the development of cancer vaccines that target neoantigens; Scientific research services in the biomedical sciences fields of molecular biology, cell biology, genetics, and immunology; Compiling medical data for research purposes in the field of gene mutations in rare and common cancers for evaluation and assessing tumor biology, prognosis, and treatment and patient drug response; Providing non-downloadable on-line software, software applications, software tools, and databases using natural language processing and machine learning algorithms, for extracting, characterizing, defining, annotating, curating, structuring, and communicating clinical information and health records; compiling medical data for research purposes. |
Classification Information
| International Class | 036 - Insurance; financial affairs; monetary affairs; real estate affairs. |
| US Class Codes | 100, 101, 102 |
| Class Status Code | 6 - Active |
| Class Status Date | Monday, July 14, 2025 |
| Primary Code | 036 |
| First Use Anywhere Date | Saturday, December 31, 1988 |
| First Use In Commerce Date | Saturday, December 31, 1988 |
| International Class | 041 - Education; providing of training; entertainment; sporting and cultural activities. |
| US Class Codes | 100, 101, 107 |
| Class Status Code | 6 - Active |
| Class Status Date | Monday, July 14, 2025 |
| Primary Code | 041 |
| First Use Anywhere Date | Saturday, December 31, 1988 |
| First Use In Commerce Date | Saturday, December 31, 1988 |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Monday, July 14, 2025 |
| Primary Code | 042 |
| First Use Anywhere Date | Saturday, December 31, 1988 |
| First Use In Commerce Date | Saturday, December 31, 1988 |
| International Class | 044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Monday, July 14, 2025 |
| Primary Code | 044 |
| First Use Anywhere Date | Saturday, December 31, 1988 |
| First Use In Commerce Date | Saturday, December 31, 1988 |
Trademark Owner History
| Party Name | Memorial Sloan-Kettering Cancer Center |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | New York, NY 10065
US |
Trademark Events
| Event Date | Event Description |
| Monday, July 14, 2025 | NEW APPLICATION ENTERED |
| Monday, July 14, 2025 | APPLICATION FILING RECEIPT MAILED |
| Tuesday, November 18, 2025 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Tuesday, December 2, 2025 | ASSIGNED TO EXAMINER |
| Tuesday, December 9, 2025 | NON-FINAL ACTION WRITTEN |
| Tuesday, December 9, 2025 | NON-FINAL ACTION E-MAILED |
| Tuesday, December 9, 2025 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Friday, February 13, 2026 | APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED |
| Friday, February 13, 2026 | APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED |
| Tuesday, June 9, 2026 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Tuesday, June 9, 2026 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Wednesday, June 10, 2026 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Wednesday, June 10, 2026 | APPROVED FOR PUB - PRINCIPAL REGISTER |
